---
title: "Wednesday 6/3 Insider Buying Report: IFF, AUPH"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288602250.md"
description: "On June 3, insider buying activity was reported for International Flavors & Fragrances (IFF) and Aurinia Pharmaceuticals (AUPH). IFF Director Paul J. Fribourg purchased 273,500 shares at $74.29 each, totaling $20.32 million. Concurrently, AUPH CEO Kevin Tang bought 814,606 shares worth $12.46 million at $15.29 per share. Both stocks saw price increases on the day of the reports."
datetime: "2026-06-03T15:30:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288602250.md)
  - [en](https://longbridge.com/en/news/288602250.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288602250.md)
generator: "portal-rs"
---

# Wednesday 6/3 Insider Buying Report: IFF, AUPH

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

At International Flavors & Fragrances, a filing with the SEC revealed that on Monday, Director Paul J. Fribourg purchased 273,500 shares of IFF, for a cost of $74.29 each, for a total investment of $20.32M. International Flavors & Fragrances is trading up about 2.5% on the day Wednesday. Before this latest buy, Fribourg purchased IFF at 2 other times during the past twelve months, for a total cost of $11.97M at an average of $69.64 per share. 

And on Tuesday, Chief Executive Officer Kevin Tang bought $12.46M worth of Aurinia Pharmaceuticals, buying 814,606 shares at a cost of $15.29 each. Before this latest buy, Tang purchased AUPH on 2 other occasions during the past year, for a total cost of $26.28M at an average of $11.94 per share. Aurinia Pharmaceuticals is trading up about 3.6% on the day Wednesday. Tang was up about 4.6% on the buy at the high point of today's trading session, with AUPH trading as high as $16.00 at last check today. 

**VIDEO: Wednesday 6/3 Insider Buying Report: IFF, AUPH**

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

### Related Stocks

- [AUPH.US](https://longbridge.com/en/quote/AUPH.US.md)
- [IFF.US](https://longbridge.com/en/quote/IFF.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Diamond Hill Capital Management LLC Investment Advisor Purchases New Position in Aurinia Pharmaceuticals Inc $AUPH](https://longbridge.com/en/news/296195979.md)
- [Mitsubishi UFJ Asset Management Co. Ltd. Invests $70.13 Million in International Flavors & Fragrances Inc. $IFF](https://longbridge.com/en/news/296465268.md)
- [Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug](https://longbridge.com/en/news/296500759.md)
- [Aurinia settles Teva patent suit, sets generic voclosporin launch no earlier than Dec. 7, 2036](https://longbridge.com/en/news/296394736.md)
- [IFF President, Scent Ana Paula Teles de Mendonca disposes of $475,293 common shares](https://longbridge.com/en/news/296361330.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**